Science Links Japan | Journal of Clinical Therapeutics & Medicines

List of Jounal Titles

A to Z index of Journal Title. Choose a letter.

A/ B/ C/ D/ E/ F/ G/ H/ I/ J/ K/ L/ M/ N/ O/ P/ Q/ R/ S/ T/ U/ V/ W/ X/ Y/ Z/ 0/ 1/ 2/ 3/ 4/ 5/ 6/ 7/ 8/ 9

Journal of Clinical Therapeutics & Medicines

Present condition of the trial case after the new GCP operation.
Phase I Study of CD-13, a Diagnostic Agent for H. Pylori Infection Used in the 13C-Urea Breath Test.
Phase II Study of CD-13, a Diagnostic Agent for H. pylori infection. Clinical Pharmacological Study of 13C-Urea Breath Test Conditions.
Effect of CS-905(Azelnidipine) on Cardiovascular Dynamics in Essential Hypertensive Patients with Exercise. Double Blind Crossover Placebo Controlled Study.
Clinical Evaluation of Omeprazole on Reflux Esophagitis Resistant to H2 Receptor Antagonists. (I). Effect of Healing and Safety.
Effects of Agaricus Hexoses of Carbohydrate Complex(Agaricus HCC) for the Treatment of Chronic Hepatitis C.
Long-term Clinical Evaluation of Hypen on Osteoarthritis of the Knee.
Effects of Decrat on Intractable Cutaneous Ulcer.
2
A Study on Efficacy and Safety of 20mg/day, 40mg/day, 80mg/day of Seratrodast, a Thromboxane A2 Receptor Antagonist on Perennial Allergic Rhinitis Patients. An Early Phase II Study.
Evaluation of Effect of Seratrodast on Nasal Passage Patency in Perennial Allergic Rhinitis by Acoustic Rhinometry.
Dose Finding Study of Seratrodast, a Thromboxane A2 Antagonist, in Patients with Perennial Allergic Rhinitis. A Multi-center, Double-blind Comparative Study.
Study on Administration of 80mg/day and 120mg/day of Seratrodast in Perennial Allergic Rhinitis Patients.
Clinical Evaluation of Seratrodast, a Thromboxane A2 Antagonist, in Patients with Perennial Allergic Rhinitis. Multi-center Comparative Double-blind Test with Terfenadine.
Effect of Combination Therapy with Seratrodast and Mequitazine on Perennial Allergic Rhinitis.
Clinical Study of Seratrodast, a Thromboxane A2 Antagonist, in Perennial Allergic Rhinitis for 12-week Target Date.
Efficacy and Safety on 12-week Administration of Seratrodast, a Thromboxane A2 Antagonist, in Patients with Perennial Allergic Rhinitis.
Clinical Evaluation on 12-week Administration of Seratrodast, a Thromboxane A2 Antagonist, in Perennial Allergic Rhinitis.
3
Internationalization of clinical trial. Aiming at improvement of quality. I. Clinical trial toward the twenty-first century.
Internationalization of clinical trial. Aiming at improvement of quality. II. PK/PD study.
Internationalization of clinical trial. Aiming at improvement of quality. III. Design of clinical trial of drug.
Internationalization of clinical trial. Aiming at improvement of quality. IV. Ethics in clinical trial of drug. Operational experience in Canada.
Internationalization of clinical trial. Aiming at improvement of quality. V. Acceptance of overseas clinical data and bridging study.
Effect of Azelnidipine, CS-905, on Diurnal Blood Pressure Variation and Heart Rate Variability in Patients with Essential Hypertension.
Effect of CS-905(Azelnidipine) on Renal Function in Essential Hypertension.
Clinical Usefulness of TU-199, a New Anti-ulcer Agent(Benatoprazole), in the treatment of Peptic Ulcer. A Double Blind, Randomized, Comparative Study with Omeprazole.
Effect of Shakuyaku-kanzo-to(Tsumura TJ-68) on Muscle Cramps Accompanying Cirrhosis in a Placebo-controlled Double-blind Parallel Study.
Phase III Clinical Study of AG-901 Ophthalmic Solution on Primary Open-Angle Glaucoma and Ocular Hypertension. A Multicenter, Double-blind Comparison with 0.5% Timolol Maleate.
4
Skin Irritation of CLDM-T in Normal Volunteers Studied by Patch Test and Photopatch Test.
Study of Safety and Pharmacokinetics of CLDM-T in Normal Volunteers.
The Clinical Phase II Study of CLDM-T Gel in the Treatment of Acne Vulgaris - Double-blind Comparative Study, Evaluation of Efficacy, Safety and Optimal Concentration of CLDM-T Gel in the Treatment of Acne Vulgaris.
Phase III Clinical Study of Clindamycin Phosphate Topical Gel(CLDM-T) in the Treatment of Acne Vulgaris - Randomized Comparative Study with Nadifloxacin Cream as a Control Drug.
The Phase III Open Label Study of CLDM-T Gel in the Treatment of Acne Vulgaris.
The Clinical Trial of CLDM-T Gel in the Treatment of Acne Vulgaris-The Phase III Open Label Study.
5
Quality control and quality assurance of data required from a trial case requester.
International cooperation of trial cases and present state of data management in Europe and America.
Trial case data management in electronified medical care system.
Local development and data management.
Multiple facilities cooperated clinical trials and data management.
Data management from the viewpoint of monitoring and auditing.
New antidepressive drug.
History of origin of SMO (Site Management Organization) and its function.
Clinicoparmacological Study on Drug Interaction of Mosapride in Healthy Volunteers. Effects on Electrocardiogram and Pharmacokinetics by Concomitant Administration of Mosapride and Erythromycin.
Pharmacokinetics of CS-905(Azelnidipine) in Patients with Renal Insufficiency.
Pharmacokinetic Study of CS-905(Azelnidipine) in Elderly Patients with Essential Hypertension.
Studies of Helicobacter pylori Eradication Treatment. Modification of Eradication Therapy to Gain a Higher Eradication Rate.
6
Effect of CS-905 (Azelnidipine) on Diurnal Blood Pressure Variation in Patients with Essential Hypertension. Early Phase II Clinical Study.
Efficacy and Safety of CS-905 (Azelnidipine) in Patients with Essential Hypertension. Early Phase II Clinical Study (Pre-pilot and Pilot I).
Efficacy and Safety of CS-905 (Azelnidipine) in Patients with Essential Hypertension. Early Phase II Clinical Study (Pilot II).
Late Phase II Study of CS-905, Azelnidipine, in Patients with Essential Hypertension. A Multi-center, Double-blind Comparative Study for Evaluation of Optimal Dose.
Efficacy and Safety of CS-905 (Azelnidipine) Monotherapy on Essential Hypertension in the Long-term Treatment.
Efficacy and Safety of CS-905 (Azelnidipine) in Patients with Severe Hypertension.
The Efficacy and Safety of CS-905 (Azelnidipine) in the Treatment of Essential Hypertensives with Renal Disfunction and Renal Parenchymal Hypertensives.
Clinical Study of CS-905 (Azelnidipine) on Antiarteriosclerotic Effect and Protective Effect of Renal Function in Patients with Essential Hypertension.
7
Phase I Study of Ropivacaine Hydrochloride, a Long Acting Local Anesthetic.
Safety Investigation of Ropivacaine Hydrochloride, a Long Acting Local Anesthetic, for Epidurl Anesthesia. Phase II Trial.
Dosage Investigation of Ropivacaine Hydrochloride, a Long Acting Local Anesthetic, for Epidural Anesthesia. Phase II Trial.
Investigation of Infusion Rate on Efficacy and Safety in Postoperative Analgesia with Long Acting Local Anesthetics Ropivacaine Hydrochloride. Phase II Trail.
Dose Response of Ropivacaine Hydrochloride, a Long Acting Local Anesthetic, for Brachial Plexus Block. Phase II Trial.
Clinical Assessment of the Long Acting Local Anesthetic Ropivacaine Hydrochloride for Epidural Anesthesia in Elderly Patients. Phase II Trial.
Clinical Assessment of Ropivacaine Hydrochloride 10mg/ml Injection, a Long Acting Local Anesthetic, for Epidural Anesthesia. Phase II Trial.
Efficacy and Safety Investigation of Ropivacaine Hydrochloride, a Long Acting Local Anesthetic, for Brachial Plexus Block. Phase III Trial.
Clinicl Investigation of 7.5mg/ml Ropivacaine Hydrochloride, a Long Acting Local Anesthetic, in Epidural Anesthesia. Double blind Comparative Study with Bupivacaine Hydrochloride.
Clinical Investigation of Epidural Infusion of Ropivacaine Hydrochloride, a Long Acting Local Anesthetic, in Postoperative Analgesia. Phase III Trial.
Clinical Investigation of Ropivacaine Hydrochloride, a Long Acting Local Anesthetic, for Postoperative Analgesia. Phase III Trial.
Efficacy and Safety Investigation of Ropivacaine Hydrochloride, a Long Acting Local Anesthetic, for Epidural Anesthesia. Phase III Trial.
8
Future clinical trial. They consider endpoints. 1 From the viewpoint of the administration.
Future clinical trial. They consider endpoints. 2 On the drug acting on dementia.
Future clinical trial. They consider endpoints. 3 On the drug for treatment of osteoporosis.
Future clinical trial. They consider endpoints. 4 On the antiallergic agent.
Future clinical trial. They consider endpoints. 5 On the psychophysiologic disorder drug.
Future clinical trial. They consider endpoints. 6 From the viewpoint of the medical statistics.
The review meeting of the consideration in which trial case is smoothly promoted.
The Effects of CGP33101 on Adult Patients with Intractable Epilepsy.
Clinical Evaluation of Etodolac (Hypen) in Patients with Low Back Pain.
Evaluation on Long-term Administration of IPD-Capsule (suplatast tosilate) for Atopic Dermatitis.
Clinical Evaluation of GJ-0956 on Essential Hypertension-A Double-blind Comparative Study with Nitrendipine.
9
From the viewpoint of all human medical treatment and psychosomatic medicine.
The clinical trial after Clinical Research Coordinator (CRC) introduction. From the viewpoint of doctor in charge.
Way of the combination of training and trial case team of Clinical Research Coordinator. They consider the execution of the trial case which stood at the patient viewpoint.
Way of the combination of training and trial case team of Clinical Research Coordinator. From the viewpoint of the pharmacist.
Way of the combination of training and trial case team of Clinical Research Coordinator. From the viewpoint of the nurse.
Way of the combination of training and trial case team of Clinical Research Coordinator. From the standpoint of national university hospital pharmacy.
Efficacy and Safety of CS-905 (Azelnidipine) Combination Therapy on Essential Hypertention.
Dose Response of Ropivacaine Hydrochloride, a Long Acting Local Anesthetic for Regional Infiltration Anesthesia-Phase II Trial.
Efficacy and Safety Investigation of Ropivacaine Hydrochloride, a Long Acting Local Anesthetic, for Regional Infiltration Anesthesia-Phase III Trial.
11
Background of informed consent and ideal way of IRB.
Research and development of the drug of our country under mega competition design and medical treatment for healthcare reform. The problem which the drug economics should fulfil.
Diagnosis and treatment of the infant disease. 1. The pneumonia.
Diagnosis and treatment of the infant disease. 1. The chronic nephritis syndrome ( persistence proteinuria and hematuria syndrome, asymptomatic proteinuria and hematuria syndrome, recurrent hematuria syndrome, persistence hematuria syndrome ).
Diagnosis and treatment of the infant disease. 1. The viral hepatitis.
Safety and Efficacy at the Long-term Treatment of Temocapril Hydrochloride(Acecol Tablet) in Patients with Hypertension. Postmarketing Surveillance Study.
Clinical Effect of Itopride Hydrochloride on the Digestive Symptoms of Chronic Gastritis with Reflux Esophagitis.
12
Pediatric diseases series. Diagnosis and treatment of pediatric diseases. II. Upper respiratory inflammation. Intractable cold etc.
Pediatric diseases series. Diagnosis and treatment of pediatric diseases. II. Arrhythmia.
Pediatric diseases series. Diagnosis and treatment of pediatric diseases. II. Infectious enteritis.
An Open, Single and Repeated Topical Application Study of OCT Ointment to Investigate Its Safety and Pharmacokinetics in Healthy Volunteers - Phase I Clinical Study.
A Single-blind Study of OCT Ointment to Investigate Its Skin Safety in Healthy Volunteers Using Open Application, Simple Patch Tests and Photopatch Tests - Phase I Clinical Study.
Bioequivalency study between Th1165a HFA MDI and Th1165a CFCs MDI - A Two Period, Single Dose, Double Blind, Crossover Study with Two Treatment in Patients with Bronchial Asthma.